57.71
price up icon0.54%   0.31
after-market アフターアワーズ: 57.64 -0.07 -0.12%
loading
前日終値:
$57.40
開ける:
$57.89
24時間の取引高:
1.22M
Relative Volume:
0.91
時価総額:
$5.58B
収益:
$7.50M
当期純損益:
$-345.91M
株価収益率:
-13.24
EPS:
-4.3602
ネットキャッシュフロー:
$-280.51M
1週間 パフォーマンス:
+5.83%
1か月 パフォーマンス:
+1.51%
6か月 パフォーマンス:
+49.28%
1年 パフォーマンス:
+53.73%
1日の値動き範囲:
Value
$56.90
$58.53
1週間の範囲:
Value
$53.80
$58.53
52週間の値動き範囲:
Value
$28.19
$63.95

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
名前
Xenon Pharmaceuticals Inc
Name
セクター
Healthcare (1106)
Name
電話
(604) 484-3300
Name
住所
200 - 3650 GILMORE WAY, BURNABY
Name
職員
370
Name
Twitter
Name
次回の収益日
2026-05-11
Name
最新のSEC提出書
Name
XENE's Discussions on Twitter

Compare XENE vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
XENE icon
XENE
Xenon Pharmaceuticals Inc
57.71 5.55B 7.50M -345.91M -280.51M -4.3602
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-02-24 開始されました Wolfe Research Outperform
2025-09-03 再開されました Wells Fargo Overweight
2025-05-07 開始されました Chardan Capital Markets Buy
2025-02-11 開始されました Deutsche Bank Buy
2024-10-10 再開されました Raymond James Outperform
2024-10-01 開始されました H.C. Wainwright Buy
2024-01-04 開始されました Citigroup Buy
2023-12-08 開始されました Robert W. Baird Outperform
2023-10-24 再開されました Cantor Fitzgerald Overweight
2023-04-25 開始されました Cantor Fitzgerald Overweight
2022-12-14 開始されました Goldman Buy
2022-12-12 開始されました Cowen Outperform
2022-11-28 開始されました Wells Fargo Overweight
2022-10-19 開始されました Raymond James Outperform
2022-08-29 開始されました BofA Securities Buy
2022-07-21 開始されました JP Morgan Overweight
2021-10-28 開始されました RBC Capital Mkts Outperform
2020-10-02 開始されました SVB Leerink Outperform
2020-07-21 開始されました Needham Buy
2020-06-01 再開されました Jefferies Buy
2020-03-25 開始されました Wedbush Outperform
2020-01-08 開始されました William Blair Outperform
2019-09-20 開始されました Guggenheim Buy
2018-08-08 繰り返されました Stifel Buy
2017-03-13 開始されました Jefferies Buy
2016-10-21 開始されました Stifel Buy
2016-09-26 開始されました Guggenheim Buy
2016-04-14 繰り返されました Jefferies Buy
2015-10-30 再開されました Jefferies Buy
2014-12-02 開始されました Canaccord Genuity Buy
すべてを表示

Xenon Pharmaceuticals Inc (XENE) 最新ニュース

pulisher
May 02, 2026

XENON PHARMACEUTICALS INC (NASDAQ:XENE) Breakout Setup Combines 9/10 Technical Strength with 9/10 Consolidation Quality - ChartMill

May 02, 2026
pulisher
May 01, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026
pulisher
May 01, 2026

Seven new Xenon hires get stock awards priced at $56.04 - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Jennison Associates LLC Boosts Stock Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

May 01, 2026
pulisher
May 01, 2026

Pictet Asset Management Holding SA Cuts Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

May 01, 2026
pulisher
Apr 30, 2026

Xenon to Report Q1 2026 Financial Results on May 7, 2026 - The Manila Times

Apr 30, 2026
pulisher
Apr 30, 2026

May 7 after the bell: Xenon to give Q1 update, host webcast - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - MarketBeat

Apr 30, 2026
pulisher
Apr 28, 2026

Xenon spikes, Theravance sinks after phase III readouts in March - BioWorld News

Apr 28, 2026
pulisher
Apr 26, 2026

Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference - MarketBeat

Apr 26, 2026
pulisher
Apr 25, 2026

XENE Price Today: Xenon Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 25, 2026
pulisher
Apr 24, 2026

Xenon Pharmaceuticals Reports Positive Phase 3 Azetukalner Results - HarianBasis.co

Apr 24, 2026
pulisher
Apr 24, 2026

Peregrine Capital Management LLC Invests $7.84 Million in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Apr 24, 2026
pulisher
Apr 23, 2026

Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here - Yahoo Finance

Apr 23, 2026
pulisher
Apr 22, 2026

Xenon's Phase 3 Supports A 'Buy' Despite Its Premium (NASDAQ:XENE) - Seeking Alpha

Apr 22, 2026
pulisher
Apr 22, 2026

[ARS] Xenon Pharmaceuticals Inc. SEC Filing - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

Xenon Pharmaceuticals (XENE) 2026 proxy details board elections and new equity plan - Stock Titan

Apr 22, 2026
pulisher
Apr 21, 2026

Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), Biogen (BIIB) - The Globe and Mail

Apr 21, 2026
pulisher
Apr 20, 2026

Needham Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $80 - Moomoo

Apr 20, 2026
pulisher
Apr 20, 2026

RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN

Apr 20, 2026
pulisher
Apr 20, 2026

Stifel sees Xenon Pharmaceuticals stock reaching $2B in peak sales - Investing.com

Apr 20, 2026
pulisher
Apr 20, 2026

Xenon Pharmaceuticals (XENE) Reports Positive Phase 3 Study Resu - GuruFocus

Apr 20, 2026
pulisher
Apr 19, 2026

Xenon Pharma’s azetukalner shows 53% seizure reduction in trial By Investing.com - Investing.com South Africa

Apr 19, 2026
pulisher
Apr 19, 2026

Xenon presents positive epilepsy drug trial data at AAN meeting - Investing.com

Apr 19, 2026
pulisher
Apr 19, 2026

Xenon presents positive epilepsy drug trial data at AAN meeting By Investing.com - Investing.com Canada

Apr 19, 2026
pulisher
Apr 19, 2026

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting - The Manila Times

Apr 19, 2026
pulisher
Apr 19, 2026

Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results for Azetukalner in Focal Onset Seizures at AAN 2026 - Quiver Quantitative

Apr 19, 2026
pulisher
Apr 19, 2026

Xenon Pharma’s azetukalner shows 53% seizure reduction in trial - Investing.com UK

Apr 19, 2026
pulisher
Apr 19, 2026

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results - GlobeNewswire

Apr 19, 2026
pulisher
Apr 16, 2026

Xenon to Present at Upcoming Investor Conferences - Sahm

Apr 16, 2026
pulisher
Apr 16, 2026

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - MarketBeat

Apr 16, 2026
pulisher
Apr 15, 2026

Xenon to Spotlight Neurology Pipeline at Series of 2026 Investor Conferences - TipRanks

Apr 15, 2026
pulisher
Apr 14, 2026

Xenon Expands 2025 Inducement Equity Incentive Plan - The Globe and Mail

Apr 14, 2026
pulisher
Apr 14, 2026

Xenon Pharmaceuticals Amends 2025 Inducement Equity Incentive Plan for Nasdaq Compliance and Employee Attraction 10 - Minichart

Apr 14, 2026
pulisher
Apr 13, 2026

Xenon Pharmaceuticals (XENE) boosts 2025 inducement equity plan share reserve - Stock Titan

Apr 13, 2026
pulisher
Apr 11, 2026

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Apr 11, 2026
pulisher
Apr 09, 2026

Certain Restricted Stock Units of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026. - marketscreener.com

Apr 09, 2026
pulisher
Apr 09, 2026

Certain Stock Options of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026. - marketscreener.com

Apr 09, 2026
pulisher
Apr 09, 2026

Certain Common Shares of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026. - marketscreener.com

Apr 09, 2026
pulisher
Apr 09, 2026

Published on: 2026-04-09 12:46:57 - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 08, 2026

Xenon Pharmaceuticals to present azetukalner epilepsy data at AAN By Investing.com - Investing.com Australia

Apr 08, 2026
pulisher
Apr 07, 2026

Xenon Pharmaceuticals to present azetukalner epilepsy data at AAN - Investing.com

Apr 07, 2026

Xenon Pharmaceuticals Inc (XENE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):